NFKB1 and COVID-19: The data reported here show that patients with COVID-19 have a higher cumulative systemic exposure to lung-derived inflammatory cytokines during their illness and suggest a “cytokine monsoon” rather than “cytokine storm” might drive more severe or prolonged post-acute sequelae of infection in COVID-19 survivors through prolonged activation of NF-κB.